
A look at last week's top stories in the world of pharmacy.

A look at last week's top stories in the world of pharmacy.

A look at last week's top stories in the world of pharmacy.

Top news of the week from Specialty Pharmacy Times.

The researchers concluded that this information has implications for all privatized, market-based prescription drug plans.

Once-weekly pill has the potential to prevent 20% of new HIV infections.

An HIV protein may interact with brain cells to increase neurodegeneration.

Novel HIV treatment protected immune cells against HIV for nearly a month.

More than one-third of HIV-positive patients are not vaccinated against hepatitis B virus.

Certain hormonal forms of birth control could place women at a higher risk of contracting HIV.

ART was associated with lower rates of high-risk human papillomavirus and invasive cervical cancer among women with HIV.

Although substantial progress has been made in the advancement of HIV treatment and prevention, adherence remains a barrier for individuals taking medication on a frequent basis.

Many patients with HIV are unaware of their status, increasing risk for transmission of infection and leaving individuals susceptible to adverse events. For this reason, health advocates recommend that all individuals receive an HIV test.

Implementing a one-time screening for HIV at age 25 may be a cost-effective way to identify new infections.

Infectious disease and HIV specialists may be more willing to prescribe HIV preexposure prophylaxis than primary care providers.

Oral preexposure prophylaxis (PrEP) has the potential to prevent HIV transmission and ultimately to help eradicate this devastating viral infection.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

The Maraba virus was observed to kill latently infected HIV cells.

What has changed in HIV over time?

With the growth in pharmacy over the past 10 years, pharmacists are now at the forefront of managing many more disease states than in the past.

New research suggests that treating a common parasitic infection may reduce HIV transmission rates.

A look back at the top articles of the year on Specialty Pharmacy Times.

Enzymes that protect the immune system may malfunction and provoke cancer-related mutations.

If one-quarter of HIV-negative patients took PrEP, a significant amount of new HIV infections could be prevented.

Rattlesnake pills have received media attention due to their link with Salmonella infection.